is lantus a glp-1 for Weight Loss and Diabetes Lantus (insulin pen) Uses, Dosage,
Description
10.1056/NEJMoa1501352 127

Loss of appetite is uncommon and may indicate pancreatitis

An important observation from CVOTs in patients with T2D is that event curves for MACE diverge after 1218 months of treatment, indicating that sustained exposure is required to realize benefits in ASCVD (48)
WNT signalling is both an inducer and effector of glucagon-like peptide-1